Joylux, the global leader in intimate wellness, and Respin, the women’s midlife wellness brand founded by Academy Award-winning actress, filmmaker, entrepreneur and advocate Halle Berry, announce a global multi-facetted partnership to bring solutions to the 60 million peri/post-menopausal women suffering from common intimate health issues.…
Sofia Fund
OcuPro Roadside Cannabis Test featured on Kare 11
OcuPro, a new device from Oculogica for testing impairment after cannabis use, was featured on Kare 11 News.
The device has gone through several design iterations already, according to Joel Sanderson, Oculogica’s chief technology officer. “We’re always exploring new technologies; improving ways to keep doing things better,” said Sanderson.…
New Roadside Cannabis Test to Be Piloted by Police Departments Across the U.S.
Neuro-diagnostic company Oculogica today announced the launch of OcuPro, the fastest roadside cannabis test with immediate results, along with pilots planned with several police departments across the U.S. Officers administer the 45-second long test and receive an immediate indication of recent cannabis use and impairment.…
Women Investment Pioneer Joy Lindsay Named 2023 Entrepreneur of the Year by University of Minnesota
MINNNEAPOLIS (April 18, 2023) – Sofia Fund, the angel investment firm focused exclusively on women-led companies, announces that its managing partner, long-term investor and entrepreneur Joy Lindsay, is the recipient of the 2023 Entrepreneur of the Year Award, presented by the University of Minnesota.…
Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Cognition Therapeutics reported on 2nd quarter financial results and business updates including optimistic advancements in clinical trials.
Cognition Therapeutics Presents New Proteomic Data on Effect of CT1812 Treatment on Normalization of Disrupted Alzheimer’s Disease Processes
Analytic results in a study of Cognition Therapeutic’s CT1812, a drug targeting mild-to-moderate Alzheimer’s disease, indicates a reduction in the YKL-40, a biomarker for inflammation associated with Alzheimer’s.
DHS S&T Awards Funds to Kenzen, a Kansas City Startup Developing Wearable Tech
DHS has selected Kenzen’s wearable technology that helps prevent heat related injuries for their SVIP program. The SVIP program identifies innovative technology that could protect employees and save lives. Read full press release here. …
ACA Honors Angel-Financed Innovation with the Prestigious Luis Villalobos Award
Atlantic City, NJ (May 19, 2022) – Recognizing the most ingenious and innovative ideas recently financed by members of the Angel Capital Association, the prestigious Luis Villalobos Award was recently awarded to two companies disrupting their fields. Recognized were Healionics, a company making dialysis safer for those in kidney failure in the Life Sciences category, and Tilt, a company revolutionizing employee leave management in the workplace, in the Technology, Services and Consumer category.…
Cognition Therapeutics Reports Year End 2021 Financial Results
StormSensor® Introduces New Technology to Identify Urban Flood Risk
As our infrastructure continues to age, systems across the U.S. will continue to fail at an alarming rate without immediate intervention. Storm Sensor’s SURFR adds a new risk assessment tool to its line of flood mitigation hardware and software.